esqLABS GmbH, Germany
Dr. Martins is a pharmacist with a Ph.D. in Pharmaceutical Sciences from the University of São Paulo, Brazil. Before joining esqLBS, he worked as a Pharmacometrics Leader at Galapagos Pharmaceuticals in Paris, France, and Research Scientist at Certara (Simcyp division) in Sheffield, England. At Galapagos, Mr. Martins was responsible for implementing and applying PBPK models to guide drug development and translational strategies. He contributed to critical decisions for oral drugs entering the clinical stage, formulation development, drug-drug interaction, late-stage development, and translational evaluation of medicines for rare diseases. While working at Certara, Dr. Martins was deeply involved with the development and qualification of the Simcyp dermal platform and training courses. He also has hands-on IVIVE, IVIVC, first-in-human dose selection, and application of PBPK in formulation development. His primary focus area is anti-inflammatory, pulmonary fibrosis, immunology, and skin diseases. Since 2019, he has been a visiting professor at the State University of Maringá, Brazil, collaborating with the post-graduate program in pharmaceutical science as graduate students' co-supervisor.